Neo-Oxy 50/50

Manufacturer
Pharmgate Animal Health | Pharmgate LLC
Effective date
2026-10-13
Label type
VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Version
10
Source
daily-update
Hydrated at
2026-10-15 01:01:28

Label at a glance#

ProductNeo-Oxy 50/50
Active ingredientOxytetracycline, Neomycin Sulfate
Label structure7 sections

Dosage and administration

Indications For Use Use Level of Oxytetracycline and Neomycin Sulfate lbs. of Neo-Oxy 50/50 ® per ton of Type C Medicated Feed Chickens For control of infectious synovitis caused by Mycoplasma synoviae , control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline. Feed continuously for 7-14 days. 100-200g/ton 2.0-4.0 For control of chronic respiratory disease (CRD) and air sac infection ...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Oxytetracycline, Neomycin
Type A Medicated Article

DESCRIPTION SECTION

Active Drug Ingredients: Oxytetracycline (from oxytetracycline dihydrate base) equivalent to 50 grams/lb. Oxytetracycline HCl. Neomycin sulfate 50 grams/lb.

Ingredients: Calcium carbonate, Roughage products, Oxytetracycline, Neomycin sulfate and Mineral oil.

INDICATIONS & USAGE SECTION

FOR USE IN THE MANUFACTURE OF MEDICATED ANIMAL FEEDS

PRECAUTIONS SECTION

CAUTION: For Use in Dry Feeds ONLY. NOT FOR USE IN LIQUID FEED SUPPLEMENTS

Directions For Use

VETERINARY INDICATIONS SECTION

Indications For UseUse Level of Oxytetracycline and Neomycin Sulfatelbs. of Neo-Oxy 50/50® per ton of Type C Medicated Feed
Chickens
For control of infectious synovitis caused by Mycoplasma synoviae, control of fowl cholera caused by Pasteurella multocida susceptible to oxytetracycline. Feed continuously for 7-14 days.100-200g/ton2.0-4.0
For control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to oxytetracycline. Feed continuously for 7-14 days.400g/ton8.0
For reduction of mortality due to air sacculitis (air sac infection) caused by Escherichia coli susceptible to oxytetracycline. Feed continuously for 5 days.500g/ton10.0
RESIDUE WARNING: AT 500 G/TON LEVEL, WITHDRAW 24 HOURS BEFORE SLAUGHTER. ZERO-DAY WITHDRAWAL PERIOD FOR LOWER USE LEVELS. IN LOW CALCIUM FEEDS WITHDRAW 3 DAYS BEFORE SLAUGHTER. DO NOT FEED TO CHICKENS PRODUCING EGGS FOR HUMAN CONSUMPTION.
Turkeys
For control of hexamitiasis caused by Hexamita meleagridis susceptible to oxytetracycline. Feed continuously for 7-14 days.100g/ton2.0
For control of infectious synovitis caused by Mycoplasma synoviae susceptible to oxytetracycline. Feed continuously for 7-14 days.200g/ton4.0
For control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to oxytetracycline. Feed continuously for 7-14 days.25 mg/lb body
weight/day
16.7*
RESIDUE WARNING: AT 200 G/TON USE LEVEL OR HIGHER, WITHDRAW 5 DAYS BEFORE SLAUGHTER. ZERO-DAY WITHDRAWAL PERIOD AT 100G/TON USE LEVELS. DO NOT FEED TO TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION.
Sheep
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Feed continuously for 7-14 days. Treatment should continue 24 to 48 hours beyond remission of disease symptoms.10 mg/lb body
weight/day
24†
RESIDUE WARNING: WITHDRAW 5 DAYS BEFORE SLAUGHTER AT 10 MG/LB DOSAGE.
Swine
For Swine: For treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and treatment of bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Feed continuously for 7-14 days.10 mg/lb body
weight/day
10‡
For Breeding Swine: For control and treatment of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to oxytetracycline. Feed continuously for not more than 14 days.10 mg/lb body
weight/day
10‡
RESIDUE WARNING: WITHDRAW 5 DAYS BEFORE SLAUGHTER AT 10 MG/LB DOSAGE.
Calves, Beef Cattle, and Nonlactating Dairy Cattle
For Calves (up to 250 lbs.): For treatment of bacterial enteritis caused by Escherichia coli susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Feed continuously for 7 to 14 days in starter feed. Treatment should continue 24 to 48 hours beyond remission of disease symptoms.10 mg/lb body
weight/day
20§
For Growing Cattle (over 400 lbs.): For the reduction of the incidence of liver abscesses. Feed continuously.75mg/head/day1.5
For prevention and treatment of the early stages of shipping fever complex. Feed 3-5 days before and after arrival in feedlots.0.5-2.0g/head/day10-40
For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia (shipping fever complex) caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by Escherichia coli susceptible to neomycin. Feed continuously for 7-14 days in feed. Treatment should continue 24 to 48 hours beyond remission of disease symptoms.10 mg/lb body
weight/day
100#
RESIDUE WARNING: AT 0.5-2.0 G/HEAD/DAY AND 10 MG/LB DOSAGES: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR USE IN PRE-RUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. AT 0.5-2.0 G/HEAD/DAY AND 10 MG/LB DOSAGES: A MILK DISCARD TIME HAS NOT BEEN ESTABLISHED FOR USE IN LACTATING DAIRY CATTLE. DO NOT USE IN FEMALE DAIRY CATTLE 20 MONTHS OF AGE OR OLDER. AT 10 MG/LB DOSAGE, WITHDRAW 5 DAYS BEFORE SLAUGHTER. USE OF MORE THAN ONE PRODUCT CONTAINING NEOMYCIN OR FAILURE TO FOLLOW WITHDRAWAL TIMES MAY RESULT IN ILLEGAL DRUG RESIDUES.
Store at or below 25°C (77°F) with excursions permitted to 37°C (98.6°F)
Approved by FDA under NADA # 138-939

* If bird weighs 10 lb, consuming 0.6 lb of complete feed per day

† If lamb weighs 60 lb, consuming 1 lb of supplement per head per day

‡ If pig weighs 100 lb, consuming 4 lb of complete feed per day

§ If calf weighs 100 lb, consuming 2 lb of complete starter feed per day

Include in feed supplement based on consumption of 2 lb of supplement per head per day

# If animal weighs 500 lb, consuming 2 lb of supplement per head per day

SPL UNCLASSIFIED SECTION

Net wt. 50 LB (22.68 Kg)

Marketed by:
Pharmgate Animal Health, LLC
14040 Industrial Road
Omaha, NE 68144

Take TimeFigureFigureObserve Directions

PRINCIPAL DISPLAY PANEL - 22.68 Kg Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Neo-Oxy 50/50®

Oxytetracycline
Neomycin
Type A Medicated Article

CAUTION: Federal law restricts medicated feed containing this
veterinary feed directive (VFD) drug to use by or on the order of a
licensed veterinarian.

See mixing directions, claims, cautions and warnings on back.
Restricted Drug (California) - Use Only as Directed.
Not For Human Use.

Net wt. 50 LB (22.68 Kg)

Pharmgate
ANIMAL HEALTH

PRINCIPAL DISPLAY PANEL - 22.68 Kg Bag Label
PRINCIPAL DISPLAY PANEL - 22.68 Kg Bag Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
99e684e6-f435-feb8-d2bb-3a546f1cb768Product name220161117
b045ad64-0f28-9a02-2f9b-b34d94fb2278Product name120140508
b6082387-f592-1148-0844-bd068fd213fbProduct name120140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
51429-05551429-055-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
92026-10-01daily-update2026-10-06 02:01:24
82026-01-07full-release2026-06-01 02:45:45

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.